Company intelligence / Profile preview
Eve Health Group
- Ownership
- Private
- Development stage
- Other
Overview
Stability testing has commenced on lead products targeting erectile dysfunction and dysmenorrhoea. Data will support regulatory submissions to the Therapeutic Goods Administration. No clinical trial results reported yet.
- Therapeutic areas
- Men's HealthWomen's Health
- Modalities
- Small moleculeOral strip drug delivery systemChewable dosage forms
- Industry
- Biotech
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Eve Health Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Eve Health Group.